Subscribe To Our Free Newsletter |
Ipca Lab slips 9%, hits 52-wk low on plan to buy 33.4% stake in Unichem Lab
Brokerages believe the acquisition is expensive, given increased competition in the US generics oral solids space, rising regulatory risks and strong efforts needed to turnaround Unichem Labs